Ultevursen
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ultevursen, covering 2024-07-12 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene [Phase 2]